2009
DOI: 10.1016/j.jcws.2009.06.001
|View full text |Cite
|
Sign up to set email alerts
|

Impaired Lower Extremity Wound Healing Secondary to Sirolimus After Kidney Transplantation

Abstract: PURPOSE: Sirolimus is an immunosuppressive drug used as part of the drug regimen after kidney, liver, and heart transplantation. There have been numerous reports of transplant surgical wound healing complications secondary to sirolimus. The authors present a case of impaired wound healing in the lower extremity after kidney transplantation for a patient on sirolimus. This is one of the few reported cases that we are aware of that demonstrates the effects of sirolimus on wound healing at a nontransplant site.ME… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 17 publications
0
3
0
Order By: Relevance
“…These healing related complications are well documented in other surgical settings but have not been specifically tested in VCAs. Thus, these studies provide objective documentation that de novo sirolimus might be a particular risk for VCAs . As opposed to other solid organ transplants, in a skin‐containing VCA, the skin is a component of the transplant and the wound healing complications prevent engraftment.…”
Section: Discussionmentioning
confidence: 99%
“…These healing related complications are well documented in other surgical settings but have not been specifically tested in VCAs. Thus, these studies provide objective documentation that de novo sirolimus might be a particular risk for VCAs . As opposed to other solid organ transplants, in a skin‐containing VCA, the skin is a component of the transplant and the wound healing complications prevent engraftment.…”
Section: Discussionmentioning
confidence: 99%
“…Autologous platelet concentrate spray further enhanced granulation tissue formation leading to complete epithelialization of the wound after 4 wk[29]. In a similar situation, Devries et al[31] were unsuccessful in treating soft tissue infection on the leg of a KT recipient, that culminated in amputation. As the patient was on sirolimus, wound healing could have been compromised by the same drug[5,31,39].…”
Section: Resultsmentioning
confidence: 99%
“…37 Sirolimus may predispose to wound complications, including deep infections, cellulitis, and fascial dehiscence. 38 Likewise, chronic corticosteroid use may be associated with a twofold to fivefold increase in wound complication rates. 39 However, we were unable to evaluate the risk in specific treatment regimens as the NIS database does not provide this detail.…”
Section: Discussionmentioning
confidence: 99%